Summary

The North American therapeutic device market exemplifies creativity, technological prowess, and a dedication to improving healthcare. This market category, which includes a wide range of medical devices used to treat various illnesses, has shown amazing expansion and innovation throughout the years. The industry continues to redefine healthcare standards, from cutting-edge developments in medical imaging technologies to the creation of cutting-edge therapeutic equipment. Furthermore, therapeutic devices are not limited to imaging methods. Pacemakers, defibrillators, and insulin pumps have become indispensable in the treatment of a variety of chronic illnesses. These life-saving devices not only improve patient’s quality of life but also demonstrate the remarkable progress made in medical engineering. Furthermore, the region's strong healthcare infrastructure and aggressive regulatory environment have created a fertile foundation for market expansion. Stringent regulatory criteria protect therapeutic device safety and efficacy while also promoting innovation. The FDA's oversight, in particular, plays a critical role in defining the market landscape by instilling trust in healthcare practitioners and patients. With the introduction of telemedicine and remote patient monitoring, the therapeutic device market in North America is undergoing a paradigm shift. The inclusion of connection elements in therapeutic devices enables healthcare providers to remotely monitor patients, allowing for prompt interventions and personalised care while also empowering patients to actively participate in their treatment path. North America is a major hub for therapeutic device clinical trials. North America is home to several of the world's largest and most important clinical trials of medicinal devices. This is due in part to the country's robust research infrastructure and large patient pool. North America is a major hub for therapeutic device clinical trials. North America is home to several of the world's largest and most important clinical trials of medicinal devices. This is due in part to the country's robust research infrastructure and large patient pool.

According to the research report "North America Therapeutic Device Market Outlook, 2028," published by Bonafide Research, the North America Therapeutic Device market was valued more than USD 37 Billion in 2022. A number of world-class medical device clusters can be found throughout North America. These clusters are concentrated in areas with a high concentration of medical device companies, research institutes, and universities. Some of the most well-known medical device clusters in North America include the Boston-Cambridge cluster, the San Francisco Bay Area cluster, and the MedTech Alley cluster in Minnesota. The incorporation of AI and machine learning algorithms into medicinal devices is a watershed moment. These technologies enable devices to rapidly and accurately analyse massive volumes of patient data, assisting in diagnoses, treatment planning, and even forecasting prospective health concerns. Artificial intelligence-powered gadgets are becoming increasingly adept at recognising trends, enabling personalised treatment regimens, and optimising therapy effectiveness. The movement towards miniaturisation and wearable therapeutic equipment is gaining traction. These gadgets, which range from wearable insulin pumps to continuous glucose monitors, allow patients to be more mobile, comfortable, and convenient. Materials and sensor technology advancements have permitted the development of wearable therapeutic devices that integrate easily into patients' daily lives while providing real-time data for monitoring and treatment changes. The Internet of Things (IoT) growth in healthcare, known as the Internet of Medical Things (IoMT), is changing therapeutic devices. Connected devices allow for the interchange of data between patients, healthcare professionals, and other healthcare systems. This connectivity not only allows for remote monitoring, but it also allows for the collection of real-time data for analysis, allowing for more informed decision-making and better patient outcomes.

Based on report market is majorly divided into three major countries United States, Canada and Mexico. Among them United States accounts for the largest market for therapeutic device in North America.

The therapeutic device market in the United States has seen extraordinary growth and innovation, transforming the healthcare business. Technological advancements and a growing emphasis on customised care have propelled this business into a state of perpetual innovation and evolution. The market's evolution includes not only the launch of new devices but also the enhancement of existing ones to make them more patient-centric. Wearable technology, for example, is evolving and becoming more sophisticated, making it easier for people to easily check their health measurements. These devices let users make proactive efforts for their own well-being by monitoring vital signs, activity, sleep habits, and other aspects. The dynamics of the therapeutic device market are influenced by continuing healthcare developments and legislation, such as the Affordable Care Act (ACA) and discussions regarding healthcare costs. The changing regulatory environment has an impact on market dynamics and access to innovative products. In the United States, about 15,000 medical device businesses manufacture therapeutic devices. The United States is a major hub for medical device research and development. Numerous major colleges and research institutes across the country are dedicated to developing cutting-edge medical technologies. The United States is a major market for medical items. The country's vast and affluent population provides a healthy market for cutting-edge medical products.

Based on product market is bifurcated into insulin delivery devices, dialysis equipments, IV equipments, wound care management, and others (ventilators, sleep apnea therapeutic device, respiratory care, hearing aids). Wound care management products are significantly driving the North America therapeutic device market.

Chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, are becoming more common in North America as a result of variables such as an ageing population, an increase in diabetes incidence, and an increase in obesity rates. These wounds necessitate specialised care and ongoing management, fueling demand for improved wound care solutions. Significant improvements in wound care technologies have resulted in the introduction of novel products. Advanced wound dressings, negative pressure wound therapy devices, and bioactive wound care products improve healing outcomes while shortening healing time and increasing patient comfort. North America has a strong healthcare infrastructure and a large healthcare budget. This allows for the use of innovative therapeutic equipment, such as wound care management solutions, which significantly contribute to market growth. Outpatient care and home-based wound management are becoming more popular. Advanced wound care products that are simple to use, promote faster healing, and allow patients to treat their wounds at home have grown in popularity, propelling the market forward. The need for adequate wound care treatment is becoming more widely recognised among healthcare professionals and patients. This has increased demand for effective wound care products, boosting the therapeutic device market in North America.

Based on end user market is bifurcated into hospitals and clinics, home care settings, ambulatory care centers (ACCs) and other end user. Hospitals and clinics are major end users of therapeutic device in North America and is expected to lead the North America therapeutic device market as well. Furthermore based on indication market includes wound care, diabetes, respiratory diseases, cardiovascular disorders & hypertension, cancer, pregnancy, hearing disorders, movement disorders and other indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV).

North America has a sophisticated healthcare infrastructure, with hospitals and clinics outfitted with cutting-edge technology and a vast range of treatment gadgets. These institutions have the resources and knowledge to efficiently adopt and use diverse treatment devices. Hospitals and clinics provide extensive medical services to meet the needs of a wide range of patients. As a result, patients require a diverse range of therapeutic equipment from many specialties, such as cardiology, orthopaedics, neurology, wound care, and others. These healthcare facilities frequently engage in R&D activities, collaborating closely with medical device businesses to test and use breakthrough treatment devices. This relationship promotes the incorporation of innovative technology into clinical practice, which drives the market even further. Furthermore wound care and cardiovascular disorders & hypertension disease are major indication of therapeutic device in North America and is significantly propelling of North America as well.

Companies Covered in this report:
Novo Nordisk A/S , Sanofi S.A., Medtronic plc , Terumo Corporation, Becton, Dickinson and Company, F. Hoffmann-La Roche AG,, B. Braun Melsungen AG, Baxter International Inc., Nipro Corporation, Fresenius Medical Care AG & Co. KGaA, WS Audiology A/S, Koninklijke Philips N.V.

Considered in this report:

• Geography: North America
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• North America Therapeutic Device market Outlook with its value and forecast along with its segments
• Country-wise Therapeutic Device market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• United States
• Canada
• Mexico

By Product:

• Insulin Delivery Devices
• Dialysis Equipments
• IV Equipments
• Wound Care Management
• Others (ventilators, sleep apnea therapeutic device, respiratory care, hearing aids)

By End User:

• Hospitals and Clinics
• Home Care Settings
• Ambulatory Care Centers (ACCs)
• Other End User

By Indication:

• Wound Care
• Diabetes
• Respiratory Diseases
• Cardiovascular Disorders & Hypertension
• Cancer
• Pregnancy
• Hearing Disorders
• Movement Disorders
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Therapeutic Device industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.






***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents